Richard C. Malabre

Insider Reports History

Location
245 First Street, 14 Th Floor, Cambridge, MA
Signature
/s/Carolyn Rucci, attorney-in-fact for Richard C. Malabre
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Richard C. Malabre:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Akebia Therapeutics, Inc. SVP, Chief Accounting Officer Common Stock 267K $1.07M $4.01 Jun 9, 2025 Direct
Akebia Therapeutics, Inc. SVP, Chief Accounting Officer Stock Option (Right to buy) 321K Jun 9, 2025 Direct

Insider Reports Filed by Richard C. Malabre

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AKBA Akebia Therapeutics, Inc. Jun 9, 2025 3 -$35K 4 Jun 11, 2025 SVP, Chief Accounting Officer
AKBA Akebia Therapeutics, Inc. Jun 4, 2025 1 -$47.1K 4 Jun 5, 2025 SVP, Chief Accounting Officer
AKBA Akebia Therapeutics, Inc. Jan 31, 2025 3 -$63.4K 4 Feb 4, 2025 SVP, Chief Accounting Officer
AKBA Akebia Therapeutics, Inc. Jan 31, 2024 2 $0 4 Feb 2, 2024 Chief Accounting Officer
AKBA Akebia Therapeutics, Inc. Jan 8, 2024 0 $0 3 Jan 18, 2024 Chief Accounting Officer